Molecular Mechanisms of ARD1 in Tumors
Cancer Medicine · 2025
DOI: 10.1002/cam4.70708 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2025. Verfasst von Chunjiao Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, Kunming Medical University, Chenggong District, Kunming, Yunnan, People's Republic of China. Hauptthemen laut MEDLINE: Neoplasms, N-Terminal Acetyltransferase E. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Arrest‐deficient protein 1 (ARD1) is an acetyltransferase that acetylates the N‐terminal amino acids and internal lysine residues of proteins. It plays a crucial role in various cellular processes. The significance of ARD1 in tumor development has become increasingly evident in recent years.
Methods
This review analyzes the regulatory role of ARD1 in tumor progression by examining its involvement in processes such as cell cycle regulation, cell proliferation, metastasis, apoptosis, and autophagy. Additionally, we discuss the expression patterns and molecular mechanisms of ARD1 in different types of cancer.
Results
Elevated levels of ARD1 have been reported in several cancer types. Its increased expression is associated with various tumor characteristics, suggesting it may serve as a potential prognostic biomarker. Furthermore, ARD1 could be targeted for the development of novel cancer therapies.
Conclusion
Understanding the role of ARD1 in tumor biology provides valuable insights into potential therapeutic targets and biomarkers for cancer treatment. This review highlights the advances in ARD1‐related research and suggests that it may be a promising avenue for improving cancer prognosis and treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, Kunming Medical University, Chenggong District, Kunming, Yunnan, People's Republic of China.
- Yunnan Key Laboratory of Breast Cancer Precision Medicine, Chenggong District, Kunming, Yunnan, People's Republic of China.
ORCID-Profile: Chunjiao Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, C., Lei, H., Hou, X., & Yan, S. (2025). Molecular Mechanisms of ARD1 in Tumors. Cancer Medicine. https://doi.org/10.1002/cam4.70708
Vancouver
Yu C, Lei H, Hou X, Yan S. Molecular Mechanisms of ARD1 in Tumors. Cancer Medicine. 2025. doi:10.1002/cam4.70708
BibTeX
@article{Yu2025,
author = {Yu, Chunjiao and Lei, Hongtao and Hou, Xuefei and Yan, Shan},
title = {Molecular Mechanisms of ARD1 in Tumors},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70708}
}
EUVIMED